Yahoo Finance TFSA Investors: Should You Buy the Dip in Ark Innovation ETF?
Written by Aditya Raghunath at The Motley Fool Canada
The TFSA (Tax-Free Savings Account) is a registered account where investors can generate tax-free gains. Here, returns in the form of dividends, interests, or capital gains are exempt from Canada Revenue Agency taxes, making the TFSA an ideal account to hold growth stocks over the long term.
The ongoing sell-off provides investors a massive opportunity to buy quality companies at a lower multiple. Alternatively, you can also look to invest in growth ETFs (exchange-traded funds) especially if you don’t have the expertise or time to pick individual stocks. ETF investing provides a cost-efficient way to gain exposure to the equity market while diversifying overall risk.
Cathie Wood is among the most well-known names on Wall Street. An institutional investor, Wood’s Ark Innovation ETF (NYSE:ARKK) gained popularity in 2020 after the ETF returned over 150% to investors that year. However, the ARKK ETF is since down 54% from all-time highs. Despite the pullback, ARKK is up 258% in the last five years, significantly higher than the S&P 500 returns of 112% in this period.
Let’s see if the ARKK ETF should be part of your TFSA portfolio right now.
An overview of the ARKK ETF
An actively managed ETF, ARKK, aims to allocate a significant portion of its investments toward disruptive innovation companies. ARKK defines disruptive innovation as the introduction of a product or service that can potentially change the way the world operates.
These companies are primarily part of verticals that include fintech innovation, automation, robotics & energy storage, artificial intelligence, and DNA technologies among others. With more than US$16 billion in assets under management, the ARKK ETF has a management fee of 0.75%.
The four largest sectors represented in ARKK ETF are cloud computing, online commerce, digital media, and gene therapy. Investors will also get exposure to verticals such as the internet of things, alternative energy, and robotics, among others. Its top three holdings include growth stocks such as Tesla, Roku, and Teladoc Health.
Why investing in ARKK ETF is high risk
In an interview with CNBC last November, Cathie Wood disclosed that ARK Invest might start shorting stocks as an investment strategy. Wood said the new strategy is referred to as “ARK on steroids”. Experts believe shorting stocks is a high-risk game and Wood might be motivated by the underperformance of the company’s returns in the last year.
However, the strategy will first be tested out before it is implemented. Wood also emphasized that ARK Invest is continuing to implement a long-term approach while investing in the equity market.
The ARKK ETF provides investors with an aggressive growth option and is ideal for those with a high risk profile. Its focus on growth stocks suggests that the ETF’s beta score will be inherently high. For example, growth stocks significantly underperform the market when sentiments turn bearish. However, they also can crush the broader indexes in a bull run.
One of the ARKK ETF’s holdings, Roku, gained close to 2,000% between its IPO in late 2017 and February 2021. Right now, it’s down 68% from record highs but has still returned 547% to investors in less than five years.
The post TFSA Investors: Should You Buy the Dip in Ark Innovation ETF? appeared first on The Motley Fool Canada.
Should You Invest $1,000 In Ark Innovation Etf?
Before you consider Ark Innovation Etf, we think you’ll want to hear this.
Our S&P/TSX market doubling* Stock Advisor Canada team just released their top 10 starter stocks for 2022 that we believe could supercharge any portfolio.
Want to see if Ark Innovation Etf made our list? Get started with Stock Advisor Canada today to receive all 10 of our starter stocks, a fully stocked treasure trove of industry reports, two brand-new stock recommendations every month, and much more.
Click Here to Learn More About Stock Advisor Canada Today * Returns as of 1/18/22
More reading
Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends Roku, Teladoc Health, and Tesla.
2022
